|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
2
|
Resverlogix Corp.
|
Aug 29, 2017 08:37PM
|
|
Re: BET bromodomain protein inhibitors and AML
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 07:17AM
|
|
Re: BET bromodomain protein inhibitors and AML
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 05:08PM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Aug 30, 2017 06:18PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 30, 2017 08:17PM
|
|
Re: BETonMACE Enrollment
|
15
|
Resverlogix Corp.
|
Sep 02, 2017 12:03PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Sep 02, 2017 02:21PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
6
|
Resverlogix Corp.
|
Sep 05, 2017 10:27AM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
5
|
Resverlogix Corp.
|
Sep 05, 2017 10:44AM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
6
|
Resverlogix Corp.
|
Sep 07, 2017 11:48AM
|
|
biOasis Announces "Formation of Scientific Advisory Board"
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 07, 2017 11:51AM
|
|
Re: biOasis Announces "Formation of Scientific Advisory Board"
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 07, 2017 04:07PM
|
|
Resverlogix presentation at European Meeting on Complement in Human Disease meeting
|
4
|
Resverlogix Corp.
|
Sep 08, 2017 03:01PM
|
|
Re: Resverlogix presentation at European Meeting on Complement in Human Disease meeting
|
3
|
Resverlogix Corp.
|
Sep 08, 2017 05:10PM
|
|
Re: Resverlogix presentation at European Meeting on Complement in Human Disease meeting
|
3
|
Resverlogix Corp.
|
Sep 08, 2017 06:43PM
|
|
Re: Dr. Jeffrey L. Cummings
|
2
|
Resverlogix Corp.
|
Sep 08, 2017 07:01PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
3
|
Resverlogix Corp.
|
Sep 09, 2017 06:33PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:19AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:27AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
5
|
Resverlogix Corp.
|
Sep 11, 2017 11:21AM
|
